ChengDu ShengNuo BiotecLtd 대차 대조표 상태
재무 상태 기준 확인 5/6
ChengDu ShengNuo BiotecLtd has a total shareholder equity of CN¥918.7M and total debt of CN¥398.9M, which brings its debt-to-equity ratio to 43.4%. Its total assets and total liabilities are CN¥1.5B and CN¥609.4M respectively. ChengDu ShengNuo BiotecLtd's EBIT is CN¥95.2M making its interest coverage ratio 220.4. It has cash and short-term investments of CN¥230.6M.
주요 정보
43.4%
부채 비율
CN¥398.93m
부채
| 이자 보상 비율 | 220.4x |
| 현금 | CN¥230.62m |
| 주식 | CN¥918.65m |
| 총 부채 | CN¥609.40m |
| 총 자산 | CN¥1.53b |
최근 재무 상태 업데이트
업데이트 없음
Recent updates
ChengDu ShengNuo BiotecLtd (SHSE:688117) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Nov 04
ChengDu ShengNuo Biotec Co.,Ltd. (SHSE:688117) Stocks Shoot Up 32% But Its P/E Still Looks Reasonable
Aug 26A Look At The Fair Value Of ChengDu ShengNuo Biotec Co.,Ltd. (SHSE:688117)
Jun 19ChengDu ShengNuo BiotecLtd (SHSE:688117) Strong Profits May Be Masking Some Underlying Issues
Apr 29There's Reason For Concern Over ChengDu ShengNuo Biotec Co.,Ltd.'s (SHSE:688117) Massive 27% Price Jump
Mar 04재무 상태 분석
단기부채: 688117's short term assets (CN¥651.4M) exceed its short term liabilities (CN¥467.4M).
장기 부채: 688117's short term assets (CN¥651.4M) exceed its long term liabilities (CN¥142.0M).
부채 대 자본 내역 및 분석
부채 수준: 688117's net debt to equity ratio (18.3%) is considered satisfactory.
부채 감소: 688117's debt to equity ratio has increased from 0.4% to 43.4% over the past 5 years.
부채 범위: 688117's debt is well covered by operating cash flow (20.2%).
이자 보장: 688117's interest payments on its debt are well covered by EBIT (220.4x coverage).